Pediatric Orbital Tumors

Chapter
Part of the M.D. Anderson Solid Tumor Oncology Series book series (MDA, volume 6)

Abstract

Though pediatric orbital tumors are rarely encountered outside referral centers, ophthalmologists must maintain a strong familiarity with these entities as efficient diagnosis and treatment are often paramount for optimal outcome. Most pediatric orbital tumors are biologically benign, but depending on their growth rate and anatomic location, benign tumors in the orbit can lead to vision loss, disfigurement, and even death. In this chapter, we review the literature on and discuss the most common benign and malignant orbital tumors in the pediatric population. We discuss tumor presentation, imaging characteristics, histopathologic appearance, treatment, and prognosis. Retinoblastoma and rhabdomyosarcoma are extensively discussed in other chapters in this book.

Keywords

Doxorubicin Propranolol Excavation Ferritin Cataract 

References

  1. 1.
    Ohtsuka K, Hashimoto M, Suzuki Y. A review of 244 orbital tumors in Japanese patient during a 21-year period: origins and locations. Jpn J Ophthalmol 2005;49(1):49–55.PubMedCrossRefGoogle Scholar
  2. 2.
    Shields JA, Augsburger JJ, Donoso LA. Orbital dermoid cyst of conjunctival origin. Am J Ophthalmol 1986;101:726–9.PubMedGoogle Scholar
  3. 3.
    Shields JA, Shields CL. Orbital cysts of childhood—classification, clinical features, and management. Surv Ophthalmol 2004;49(3):281–99.PubMedCrossRefGoogle Scholar
  4. 4.
    Dutton JJ, Fowler AM, Proia AD. Dermoid cyst of conjunctival origin. Ophthal Plast Reconstr Surg 2006;22(2):137–9.PubMedCrossRefGoogle Scholar
  5. 5.
    McCollough ML, Glover AT, Grabski WJ, et al. Orbital dermoid cysts showing conjunctival epithelium. Am J Dermatopathol 1991;13:611–15.PubMedCrossRefGoogle Scholar
  6. 6.
    Sherman RP, Rootman J, LaPointe JS. Orbital dermoids: clinical presentation and management. Br J Ophthalmol 1984;68:642–52.PubMedCrossRefGoogle Scholar
  7. 7.
    Bonavolonta G, Tranfa F, de Conciliis C, et al. Dermoid cysts: 16-year survey. Ophthal Plast Reconstr Surg 1995;11:187–92.PubMedCrossRefGoogle Scholar
  8. 8.
    Emerick GT, Shields CL, Shields JA, et al. Chewing-induced visual impairment from a dumbbell dermoid cyst. Ophthal Plast Reconstr Surg 1997;13:57–61.PubMedCrossRefGoogle Scholar
  9. 9.
    Howard GR, Nerad JA, Bonavolonta G, et al. Orbital dermoid cysts located within the lateral rectus muscle. Ophthalmology 1994;101:767–71.PubMedGoogle Scholar
  10. 10.
    Blei L, Chambers JT, Liotta LA, et al. Orbital dermoid diagnosed by computed tomographic scanning. Am J Ophthalmol 1978;85:58–61.PubMedGoogle Scholar
  11. 11.
    Nugent RA, Lapointe JS, Rootman J, et al. Orbital dermoids: features on CT. Radiology 1987;165:475–8.PubMedGoogle Scholar
  12. 12.
    Sathananthan N, Moseley IF, Rose GE, et al. The frequency and clinical significance of bone involvement in outer canthus dermoid cysts. Br J Ophthalmol 1993;77:789–94.PubMedCrossRefGoogle Scholar
  13. 13.
    De Potter P, Flanders AE, Shields CL, et al. Magnetic resonance imaging of orbital tumors. Int Ophthalmol Clin 1993;33:163–73.PubMedCrossRefGoogle Scholar
  14. 14.
    Hakyemez B, Aksoy U, Yildiz H, et al. Intracranial epidermoid cysts: diffusion-weighted, FLAIR, and conventional MR findings. Eur J Radiol 2005;54:214–20.PubMedCrossRefGoogle Scholar
  15. 15.
    Grove AS Jr. Giant dermoid cysts of the orbit. Ophthalmology 1979;86:1513–20.PubMedGoogle Scholar
  16. 16.
    Traboulsi EI, Azar DT, Khattar J, et al. A-scan ultrasonography in the diagnosis of orbital dermoid cysts. Ann Ophthalmol 1988;20:229–32.PubMedGoogle Scholar
  17. 17.
    Shields JA, Kaden IH, Eagle RC Jr, et al. Orbital dermoid cysts: clinicopathologic correlations, classification, and management. The 1997 Josephine E. Schuleler lecture. Ophthal Plast Reconstr Surg 1997;13:265–76.PubMedCrossRefGoogle Scholar
  18. 18.
    Kersten RC. The eyelid crease approach to superficial lateral dermoid cysts. J Pediatr Ophthalmol Strabismus 1988;25:48–51.PubMedGoogle Scholar
  19. 19.
    Columbo, F, Holbach LM, Naumann GO. Chronic inflammation in dermoid cysts: a clinicopathologic study of 115 patients. Orbit 2000;19(2):97–107.Google Scholar
  20. 20.
    Golden RP, Shields WE 2nd, Cahill KV, et al. Percutaneous drainage and ablation of orbital dermoid cysts. J AAPOS 2007;11(5):438–42.PubMedCrossRefGoogle Scholar
  21. 21.
    Appalanarasayya K, Dev OB. Teratoma of the orbit. Int Surg 1970;54:301–3.Google Scholar
  22. 22.
    Berlin AJ, Rich LS, Hahn JF. Congenital orbital teratoma. Child’s Brain 1983;10:208–16.PubMedGoogle Scholar
  23. 23.
    Bilgic S, Dayanir V, Kiratli H, et al. Congenital orbital teratoma: a clinicopathologic case report. Ophthal Plast Reconstr Surg 1997;13:142–6.PubMedCrossRefGoogle Scholar
  24. 24.
    Ferry AP. Teratoma of the orbit: a report of two cases. Surv Ophthalmol 1965;10:434–42.PubMedGoogle Scholar
  25. 25.
    Garden JW, McManis JC. Congenital orbital–intracranial teratoma with subsequent malignancy. Case report. Br J Ophthalmol 1986;70:111–13.PubMedCrossRefGoogle Scholar
  26. 26.
    Lee GA, Sullivan TJ, Tsikleas GP, et al. Congenital orbital teratoma. Aust N Z J Ophthalmol 1997;25:63–6.PubMedCrossRefGoogle Scholar
  27. 27.
    Mahesh L, Krishnakumar S, Subramanian N, et al. Malignant teratoma of the orbit: a clinicopathological study of a case. Orbit 2003;22(4):305–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Soares EJC, Lopes KDS, Andrafe JDS, et al. Orbital malignant teratoma. A case report. Orbit 1983;2:235–42.CrossRefGoogle Scholar
  29. 29.
    Chang DF, Dallow RL, Walton DS. Congenital orbital teratoma: report of a case with visual preservation. J Pediatr Ophthalmol 1980;17:88–95.Google Scholar
  30. 30.
    Itami K, Traboulsi EI, Karim FWA, et al. Conservative surgery in orbital teratoma. Orbit 1986;5:61–5.CrossRefGoogle Scholar
  31. 31.
    Gundalp I, Gunduz K. Vascular tumors of the orbit. Doc Ophthalmol 1995;89:337–45.CrossRefGoogle Scholar
  32. 32.
    Dadras SS, North PE, Bertoncini J, et al. Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol 2004;17(9):1068–79.PubMedCrossRefGoogle Scholar
  33. 33.
    Haik BG, Jakobiec FA, Ellsworth RM, et al. Capillary hemangioma of the lids and orbit: an analysis of the clinical features and therapeutic results in 101 cases. Ophthalmology 1979;86:760–92.PubMedGoogle Scholar
  34. 34.
    Haik BG, Karcioglu ZA, Goson RA, et al. Capillary hemangioma (infantile periocular hemangioma). Surv Ophthalmol 1994;38:399–426.PubMedCrossRefGoogle Scholar
  35. 35.
    Byrne SF, Green RL. Ultrasound of the Eye and Orbit. St. Louis, MO: Mosby-Yearbook, 1992:332.Google Scholar
  36. 36.
    Balchunas ER, Quencer RM, Byrne SF, et al. Correlative of the computed tomographic, ultrasonographic, and pathological characteristics of cavernous versus capillary hemangiomas of the orbit. J Clin Neuroophthalmol 1983;6:14.Google Scholar
  37. 37.
    Jiang XW, Wang GH, Li JH, et al. Expression of glucocorticoid receptor isoforms in cutaneous hemangiomas and vascular malformations. Chin Med J 2005;118(12):977–81.PubMedGoogle Scholar
  38. 38.
    Cogen MS, Elsas FJ. Eyelid depigmentation following corticosteroid injection for infantile ocular adnexal hemangioma. J Pediatr Ophthalmol Strabismus 1989;26:35–8.PubMedGoogle Scholar
  39. 39.
    Wilson MW, Hoehn ME, Haik BG, et al. Low-dose cyclophosphamide and interferon alpha 2a for the treatment of capillary hemangioma of the orbit. Ophthalmology 2007;114(5):1007–11.PubMedCrossRefGoogle Scholar
  40. 40.
    Deans RM, Harris GJ, Kivlin JD. Surgical dissection of capillary hemangiomas. An alternative to intralesional corticosteroids. Arch Ophthalmol 1992;110:1743–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Burstein FD, Simms C, Cohen SR, et al. Intralesional laser therapy of extensive hemangiomas in 100 consecutive pediatric patients. Ann Plast Surg 2000;44(2):188–94.PubMedCrossRefGoogle Scholar
  42. 42.
    Léauté-Labrèze CE, Hubiche T, Boralevi F, et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008;358(24):2649–51.PubMedCrossRefGoogle Scholar
  43. 43.
    Verity DH, Rose GE, Restori M. The effect of intralesional steroid injections on the volume and blood flow in periocular capillary haemangiomas. Orbit 2008;27(1):41–7.PubMedCrossRefGoogle Scholar
  44. 44.
    Kavanagh EC, Heran MK, Peleg A, et al. Imaging of the natural history of an orbital capillary hemangioma. Orbit 2006;25(1):69–72.PubMedCrossRefGoogle Scholar
  45. 45.
    Egbert JE, Paul S, Engel WK, et al. High injection pressure during intralesional injection of corticosteroids into capillary hemangiomas. Arch Ophthalmol 2001;119(5):677–83.PubMedGoogle Scholar
  46. 46.
    O’Keefe M, Lanigan B, Byrne SA. Capillary haemangioma of the eyelids and orbit: a clinical review of the safety and efficacy of intralesional steroid. Acta Ophthalmol Scand 2003;81(3):294–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Schwartz SR, Kodsi SR, Blei F, et al. Treatment of capillary hemangiomas causing refractive and occlusional amblyopia. J AAPOS 2007;11(6):577–83.PubMedCrossRefGoogle Scholar
  48. 48.
    Sutula FC, Glover AT. Eyelid necrosis following intralesional corticosteroid injection for capillary hemangioma. Ophthalmic Surg 1987;18(2):103–5.PubMedGoogle Scholar
  49. 49.
    Ruttum MS, Abrams GW, Harris GJ, et al. Bilateral retinal embolization associated with intralesional corticosteroid injection for capillary hemangioma of infancy. J Pediatr Ophthalmol Strabismus 1993;30(1):4–7.PubMedGoogle Scholar
  50. 50.
    Goyal R, Watts P, Lane CM, et al. Adrenal suppression and failure to thrive after steroid injections for periocular hemangioma. Ophthalmology 2004;111(2):389–95.PubMedCrossRefGoogle Scholar
  51. 51.
    Weiss AH, Kelly JP. Reappraisal of astigmatism induced by periocular capillary hemangioma and treatment with intralesional corticosteroid injection. Ophthalmology 2008;115(2):390–7.PubMedCrossRefGoogle Scholar
  52. 52.
    Bilaniuk LT. Vascular lesions of the orbit in children. Neuroimag Clin N Am 2005;15(1):107–20.CrossRefGoogle Scholar
  53. 53.
    Selva D, Strianese D, Bonavolonta G, et al. Orbital venous-lymphatic malformations (lymphangiomas) mimicking cavernous hemangiomas. Am J Ophthalmol 2001;131(3):364–70.PubMedCrossRefGoogle Scholar
  54. 54.
    Brooks SE, Pillai JJ, Bains H. Orbital cellulitis due to occult orbital lymphangioma. South Med J 2001;94(5):532–5.PubMedGoogle Scholar
  55. 55.
    Bisdorff A, Mulliken JB, Carrico J, et al. Intracranial vascular anomalies in patients with periorbital lymphatic and lymphaticovenous malformations. AJNR Am J Neuroradiol 2007;28(2):335–41.PubMedGoogle Scholar
  56. 56.
    Vachharajani A, Paes B. Orbital lymphangioma with non-contiguous cerebral arteriovenous malformation, manifesting with thrombocytopenia (Kasabach–Merritt syndrome) and intracerebral hemorrhage. Acta Paediatr 2002;91(1):98–9.PubMedCrossRefGoogle Scholar
  57. 57.
    Huckabee RE, Raila FA. MRI and CT comparison of an orbital cavernous lymphangioma. J Miss State Med Assoc 1991;32:371–3.PubMedGoogle Scholar
  58. 58.
    Bond JB, Haik BG, Taveras JL, et al. Magnetic resonance imaging of orbital lymphangioma with and without gadolinium contrast enhancement. Ophthalmology 1992;99:1318–24.PubMedGoogle Scholar
  59. 59.
    Gelbert F, Riche MC, Reizine D, et al. MR imaging of head and neck vascular malformations. J Magn Reson Imaging 1991;1:579–84.PubMedCrossRefGoogle Scholar
  60. 60.
    Byrne SF, Green RL. Orbital ultrasound. In: Tasman W, Jaeger EA, editors. Duane’s Clinical Ophthalmology. Vol 1. Philadelphia, PA: JB Lippincott, 1991:24.Google Scholar
  61. 61.
    Esmaeli B, Prieto VG, Gonnering R, et al. Growth factor receptor expression in orbital lymphangioma: possible therapeutic implications. Orbit 2004;23(4):263–9.PubMedCrossRefGoogle Scholar
  62. 62.
    Harris GJ, Sakol PJ, Bonavolonta GT, et al. An analysis of thirty cases of orbital lymphangioma. Pathophysiologic considerations and management recommendations. Ophthalmology 1990;97:1583–92.PubMedGoogle Scholar
  63. 63.
    Wilson ME, Parker PL, Chavis RM. Conservative management of childhood orbital lymphangioma. Ophthalmology 1989;96:484–9.PubMedGoogle Scholar
  64. 64.
    Sires BS, Goins CR, Anderson RL, et al. Systemic corticosteroid use in orbital lymphangioma. Ophthal Plast Reconstr Surg 2001;17(2):85–90.PubMedCrossRefGoogle Scholar
  65. 65.
    Tawfik HA, Budin H, Dutton JJ. Lack of response to systemic corticosteroids in patients with lymphangioma. Ophthal Plast Reconstr Surg 2005;21(4):302–5.PubMedCrossRefGoogle Scholar
  66. 66.
    Schwarcz RM, Ben Simon GJ, Cook T, Goldberg RA. Sclerosing therapy as first line treatment for low flow vascular lesions of the orbit. Am J Ophthalmol 2006;141(2):333–9.PubMedCrossRefGoogle Scholar
  67. 67.
    Boulos PR, Harissi-Dagher M, Kavalec C, et al. Intralesional injection of Tisseel fibrin glue for resection of lymphangiomas and other thin-walled orbital cysts. Ophthal Plast Reconstr Surg 2005;21(3):171–6.PubMedCrossRefGoogle Scholar
  68. 68.
    de Graaf JH, Egeler RM. New insights into the pathogenesis of Langerhans cell histiocytosis. Curr Opin Pediatr 1997;9(1):46–50.PubMedCrossRefGoogle Scholar
  69. 69.
    Shields JA, Shields CL. Clinical spectrum of histiocytic tumors of the orbit. Trans Pa Acad Ophthalmol Otolaryngol 1990;42:931–7.PubMedGoogle Scholar
  70. 70.
    Harris GJ. Langerhans cell histiocytosis of the orbit: a need for interdisciplinary dialogue. Am J Ophthalmol 2006;141(2):374–8.PubMedCrossRefGoogle Scholar
  71. 71.
    Egeler RM, Annels NE, Hogendoorn PC. Langerhans cell histiocytosis: a pathologic combination of oncogenesis and immune dysregulation. Pediatr Blood Cancer 2004;42(5):401–3.PubMedCrossRefGoogle Scholar
  72. 72.
    Konrad H, Clark BJ, Rose GE. Lymphocytic, plasmacytic, histiocytic, and hematopoietic tumors of the orbit. In: Tasman W, Jaeger EA, editors. Duane’s Clinical Ophthalmology. Philadelphia, PA: Lippincott Williams & Wilkins, 2000:30–2.Google Scholar
  73. 73.
    Banna M, Oltuola PS. Orbital histiocytosis on computed tomography. J Comput Tomogr 1983;7:167–70.PubMedCrossRefGoogle Scholar
  74. 74.
    Leonidas JC, Guelfguat M, Valderrama E. Langerhans cell histiocytosis. Lancet 2003;361(9365):1293–5.PubMedCrossRefGoogle Scholar
  75. 75.
    Gündüz K, Palamar M, Parmak N, et al. Eosinophilic granuloma of the orbit: report of two cases. J AAPOS 2007;11(5):506–8.PubMedCrossRefGoogle Scholar
  76. 76.
    Kindy-Degnan NA, Laflamme P, Duprat G, et al. Intralesional steroid in the treatment of an orbital eosinophilic granuloma. Arch Ophthalmol 1991;109:617–8.PubMedCrossRefGoogle Scholar
  77. 77.
    Jubran RF, Marachelian A, Dorey F, et al. Predictors of outcome in children with Langerhans cell histiocytosis. Pediatr Blood Cancer 2005;45(1):37–42.PubMedCrossRefGoogle Scholar
  78. 78.
    Haupt R, Nanduri V, Calevo MG, et al. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society Late Effects Study Group. Pediatr Blood Cancer 2004;42(5):438–44.PubMedCrossRefGoogle Scholar
  79. 79.
    Binning MJ, Brockmeyer DL. Novel multidisciplinary approach for treatment of Langerhans cell histiocytosis of the skull base. Skull Base 2008;18(1):53–8.PubMedCrossRefGoogle Scholar
  80. 80.
    Thompson CR, Lessell S. Anterior visual pathway gliomas. Int Ophthalmol Clin 1997;37:261–79.PubMedCrossRefGoogle Scholar
  81. 81.
    Dutton JJ. Gliomas of the anterior visual pathway. Surv Ophthalmol 1994;38:427–52.PubMedCrossRefGoogle Scholar
  82. 82.
    Lee AG. Neuro-ophthalmological management of optic pathway gliomas. Neurosurg Focus 2007;23(5):E1.PubMedCrossRefGoogle Scholar
  83. 83.
    North KN. Neurofibromatosis 1 in childhood. Semin Pediatr Neurol 1998;5(4):231–42.PubMedCrossRefGoogle Scholar
  84. 84.
    Astrup J. Natural history and clinical management of optic pathway glioma. Br J Neurosurg 2003;17(4):327–35.PubMedCrossRefGoogle Scholar
  85. 85.
    Zeid JL, Charrow J, Sandu M, et al. Orbital optic nerve gliomas in children with neurofibromatosis type 1. J AAPOS 2006;10(6):534–9.PubMedCrossRefGoogle Scholar
  86. 86.
    Es SV, North KN, McHugh K, et al. MRI findings in children with neurofibromatosis type 1: a prospective study. Pediatr Radiol 1996;26:478–87.PubMedCrossRefGoogle Scholar
  87. 87.
    Pungavkar SA, Lawande MA, Patkar DP, et al. Bilateral optic pathway glioma with intracranial calcification: magnetic resonance imaging and magnetic resonance spectroscopy findings. Australas Radiol 2005;49(6):489–92.PubMedCrossRefGoogle Scholar
  88. 88.
    Liu GT. Optic gliomas of the anterior visual pathway. Curr Opin Ophthalmol 2006;17(5):427–31.PubMedCrossRefGoogle Scholar
  89. 89.
    Jahraus CD, Tarbell NJ. Optic pathway gliomas. Pediatr Blood Cancer 2006;46(5):586–96.PubMedCrossRefGoogle Scholar
  90. 90.
    Combs SE, Schulz-Ertner D, Moschos D, et al. Fractionated stereotactic radiotherapy of optic pathway gliomas: tolerance and long-term outcome. Int J Radiat Oncol Biol Phys 2005;62(3):814–9.PubMedCrossRefGoogle Scholar
  91. 91.
    Balcer LJ, Liu GT, Heller G, et al. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Am J Ophthalmol 2001;131(4):442–5.PubMedCrossRefGoogle Scholar
  92. 92.
    Tow SL, Chandela S, Miller NR, et al. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol 2003;28:262–70.PubMedCrossRefGoogle Scholar
  93. 93.
    Czyzyk E, Jóźwiak S, Roszkowski M, et al. Optic pathway gliomas in children with and without neurofibromatosis 1. J Child Neurol 2003;18(7):471–8.PubMedCrossRefGoogle Scholar
  94. 94.
    Farris SR, Grove AS Jr. Orbital and eyelid manifestations of neurofibromatosis: a clinical study and literature review. Ophthal Plast Reconstr Surg 1996;12:245–59.PubMedCrossRefGoogle Scholar
  95. 95.
    Jackson IT, Carbonnel A, Potparic Z, et al. Orbitotemporal neurofibromatosis: classification and treatment. Plast Reconstr Surg 1993;92(1):1–11.PubMedCrossRefGoogle Scholar
  96. 96.
    Tada M, Sawamura Y, Ishii N, et al. Massive plexiform neurofibroma in the orbit in a child with von Recklinghausen’s disease. Childs Nerv Syst 1998;14:210–2.PubMedCrossRefGoogle Scholar
  97. 97.
    Erb MH, Uzcategui N, See RF, et al. Orbitotemporal neurofibromatosis: classification and treatment. Orbit 2007;26(4):223–8.PubMedCrossRefGoogle Scholar
  98. 98.
    Wu CT, Lee ST, Chen JF, et al. Computer-aided design for three-dimensional titanium mesh used for repairing skull base bone defect in pediatric neurofibromatosis type 1. A novel approach combining biomodeling and neuronavigation. Pediatr Neurosurg 2008;44(2):133–9.PubMedCrossRefGoogle Scholar
  99. 99.
    Kwiat DM, Bersani TA, Hodge C, et al. Surgical technique: two-step orbital reconstruction in neurofibromatosis type 1 with a matched implant and exenteration. Ophthal Plast Reconstr Surg 2004;20(2):158–61.PubMedCrossRefGoogle Scholar
  100. 100.
    Dutton JJ, Tawfik HA, DeBacker CM, et al. Multiple recurrences in malignant peripheral nerve sheath tumor of the orbit: a case report and a review of the literature. Ophthal Plast Reconstr Surg 2001;17(4):293–9.PubMedCrossRefGoogle Scholar
  101. 101.
    Shome D, Honavar SG, Reddy VA, et al. Orbital embryonal rhabdomyosarcoma in association with neurofibromatosis type 1. Ophthal Plast Reconstr Surg 2007;23(2):147–8.PubMedCrossRefGoogle Scholar
  102. 102.
    Schatz H. Benign orbital neurilemoma: sarcomatous transformation in von Recklinghausen’s disease. Arch Ophthalmol 1971;86:268–73.PubMedCrossRefGoogle Scholar
  103. 103.
    Zagar TM, Triche TJ, Kinsella TJ. Extraosseous Ewing’s sarcoma: 25 years later. J Clin Oncol 2008;26(26):4230–2.PubMedCrossRefGoogle Scholar
  104. 104.
    Choi RY, Lucarelli MJ, Imesch PD, et al. Primary orbital Ewing sarcoma in a middle-aged woman. Arch Ophthalmol 1999;117(4):535–7.PubMedCrossRefGoogle Scholar
  105. 105.
    Guzowski M, Tumuluri K, Walker DM, et al. Primary orbital Ewing sarcoma in a middle-aged man. Ophthal Plast Reconstr Surg 2005;21(6):449–51.PubMedCrossRefGoogle Scholar
  106. 106.
    Li T, Goldberg RA, Becker B, et al. Primary orbital extraskeletal Ewing sarcoma. Arch Ophthalmol 2003;121(7):1049–52.PubMedCrossRefGoogle Scholar
  107. 107.
    Dutton JJ, Rose JG Jr, DeBacker CM, et al. Orbital Ewing’s sarcoma of the orbit. Ophthal Plast Reconstr Surg 2000;16(4):292–300.PubMedCrossRefGoogle Scholar
  108. 108.
    Sharma A, Garg A, Mishra NK, et al. Primary Ewing’s sarcoma of the sphenoid bone with unusual imaging features: a case report. Clin Neurol Neurosurg 2005;107(6):528–31.PubMedCrossRefGoogle Scholar
  109. 109.
    Henk CB, Grampp S, Wiesbauer P, et al. Ewing sarcoma. Diagnostic imaging. Radiologe 1998;38:509–22.PubMedCrossRefGoogle Scholar
  110. 110.
    Wilson DJ, Dailey RA, Griffeth MT, et al. Primary Ewing sarcoma of the orbit. Ophthal Plast Reconstr Surg 2001;17(4):300–3.PubMedCrossRefGoogle Scholar
  111. 111.
    Frandsen E. Ewing’s sarcoma of the orbit. Nord Med 1952;48:1673.Google Scholar
  112. 112.
    Ludwig JA. Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future. Curr Opin Oncol 2008;20(4):412–8.PubMedCrossRefGoogle Scholar
  113. 113.
    Leavey PJ, Collier AB. Ewing’s sarcoma: prognostic criteria, outcomes, and future treatments. Expert Rev Anticancer Ther 2008;8:617–24.PubMedCrossRefGoogle Scholar
  114. 114.
    Belgaumi AF, Kauffman WM, Jenkins JJ, et al. Blindness in children with neuroblastoma. Cancer 1997;80:1997–2004.PubMedCrossRefGoogle Scholar
  115. 115.
    Musarella M, Chan HSL, DeBoer G, et al. Ocular involvement in neuroblastoma: prognostic implications. Ophthalmology 1984;91:936–40.PubMedGoogle Scholar
  116. 116.
    Mirzai H, Baser EF, Tansug N, et al. Primary orbital neuroblastoma in a neonate. Indian J Ophthalmol 2006;54:206–8.PubMedCrossRefGoogle Scholar
  117. 117.
    Lau JJ, Trobe JD, Ruiz RE, et al. Metastatic neuroblastoma presenting with binocular blindness from intracranial compression of the optic nerves. J Neuroophthalmol 2004;24(2):119–24.PubMedCrossRefGoogle Scholar
  118. 118.
    Mortada A. Clinical characteristics of early orbital neuroblastoma. Am J Ophthalmol 1967;63:1787–93.PubMedGoogle Scholar
  119. 119.
    Messina JA, Cheng SC, Franc BL, et al. Evaluation of semi-quantitative scoring system for metaiodobenzylguanidine (mIBG) scans in patients with relapsed neuroblastoma. Pediatr Blood Cancer 2006;47(7):865–74.PubMedCrossRefGoogle Scholar
  120. 120.
    Park JR, Eggert A, Caron H. Neuroblastoma: biology, prognosis, and treatment. Pediatr Clin North Am 2008;55(1):97–120.PubMedCrossRefGoogle Scholar
  121. 121.
    Ishola TA, Chung DH. Neuroblastoma. Surg Oncol 2007;16:149–56.PubMedCrossRefGoogle Scholar
  122. 122.
    Friedman GK, Castleberry RP. Changing trends of research and treatment in infant neuroblastoma. Pediatr Blood Cancer 2007;49(7 Suppl):1060–5.PubMedCrossRefGoogle Scholar
  123. 123.
    Paulino AC. Palliative radiotherapy in children with neuroblastoma. Pediatr Hematol Oncol 2003;20(2):111–7.PubMedCrossRefGoogle Scholar
  124. 124.
    Bakhshi S, Singh P, Chawla N. Malignant childhood proptosis: study of 104 cases. J Pediatr Hematol Oncol 2008;30(1):73–6.PubMedCrossRefGoogle Scholar
  125. 125.
    Menon BS, Alagaratnam J, Juraida E, et al. Late presentation of retinoblastoma in Malaysia. Pediatr Blood Cancer 2009;52(2):215–7.PubMedCrossRefGoogle Scholar
  126. 126.
    Rootman J, Ellsworth RM, Hofbauer J, et al. Orbital extension of retinoblastoma: a clinicopathologic study. Can J Ophthalmol 1978;13:72–80.PubMedGoogle Scholar
  127. 127.
    Agarwal M, Biswas J, S K, Shanmugam MP. Retinoblastoma presenting as orbital cellulitis: report of four cases with a review of the literature. Orbit 2004;23(2):93–8.PubMedCrossRefGoogle Scholar
  128. 128.
    Foster BS, Mukai S. Intraocular retinoblastoma presenting as ocular and orbital inflammation. Int Ophthalmol Clin 1996;36:153–60.PubMedCrossRefGoogle Scholar
  129. 129.
    Antoneli CB, Steinhorst F, de Cassia Braga Ribeiro K, et al. Extraocular retinoblastoma: a 13 year experience. Cancer 2003;98:1292–8.PubMedCrossRefGoogle Scholar
  130. 130.
    Kiratli H, Bigic S, Ozerdem U. Management of massive orbital involvement of intraocular retinoblastoma. Ophthalmology 1998;105:322–6.PubMedCrossRefGoogle Scholar
  131. 131.
    Chantada G, Fandiño A, Casak S, et al. Treatment of overt extraocular retinoblastoma. Med Pediatr Oncol 2003;40(3):158–61.PubMedCrossRefGoogle Scholar
  132. 132.
    Eng C, Li FP, Abramson DH, et al. Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 1993;85(14):1121–8.PubMedCrossRefGoogle Scholar
  133. 133.
    Moll AC, Imhof SM, Bouter LM, et al. Second primary tumors in patients with hereditary retinoblastoma: a register-based follow-up study, 1945–1994. Int J Cancer 1996;67(4):515–9.PubMedCrossRefGoogle Scholar
  134. 134.
    Chung EM, Specht CS, Schroeder JW. From the archives of the AFIP. Pediatric orbit tumors and tumorlike lesions: neuroepithelial lesions of the ocular globe and optic nerve. Radiographics 2007;27(4):1159–86.PubMedCrossRefGoogle Scholar
  135. 135.
    Dunkel IJ, Aledo A, Kernan NA, et al. Successful treatment of metastatic retinoblastoma. Cancer 2000;89(10):2117–21.PubMedCrossRefGoogle Scholar
  136. 136.
    Finger PT, Harbour JW, Karcioglu ZA. Risk factors for metastasis in retinoblastoma. Surv Ophthalmol 2002;47(1):1–16.PubMedCrossRefGoogle Scholar
  137. 137.
    Bowman RJ, Mafwiri M, Luthert P, et al. Outcome of retinoblastoma in east Africa. Pediatr Blood Cancer 2008;50(1):160–2.PubMedCrossRefGoogle Scholar
  138. 138.
    Gündüz K, Müftüoglu O, Günalp I, et al. Metastatic retinoblastoma clinical features, treatment, and prognosis. Ophthalmology 2006;113(9):1558–66.PubMedCrossRefGoogle Scholar
  139. 139.
    Kim JW, Kathpalia V, Dunkel I, et al. Orbital recurrence of retinoblastoma following enucleation. Br J Ophthalmol 2008;115(8):1398–1404.Google Scholar
  140. 140.
    Kleinerman RA, Tucker MA, Tarone RE, et al. Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol 2005;23(10):2272–9.PubMedCrossRefGoogle Scholar
  141. 141.
    Abramson DH, Melson MR, Dunkel IJ, et al. Third (fourth and fifth) non-ocular tumors in survivors of retinoblastoma. Ophthalmology 2001;108(10):1868–76.PubMedCrossRefGoogle Scholar
  142. 142.
    Wong FL, Boice JD Jr, Abramson DH, et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 1997;278(15):1262–7.PubMedCrossRefGoogle Scholar
  143. 143.
    Fletcher O, Easton D, Anderson K, et al. Lifetime risks of common cancers among retinoblastoma survivors. J Natl Cancer Inst 2004;96(5):357–63.PubMedCrossRefGoogle Scholar
  144. 144.
    Porto L, Kieslich M, Schwabe D, et al. Granulocytic sarcoma in children. Neuroradiology 2004;46(5):374–7.PubMedCrossRefGoogle Scholar
  145. 145.
    Esmaeli B, Medeiros LJ, Myers J, et al. Orbital mass secondary to precursor T-cell acute lymphoblastic leukemia: a rare presentation. Arch Ophthalmol 2001;119(3):443–6.PubMedGoogle Scholar
  146. 146.
    Padillo D, Mencía E, Gutiérrez E, et al. Orbital granulocytic sarcoma in a myelodysplastic syndrome. Orbit 1999;18(4):287–90.PubMedCrossRefGoogle Scholar
  147. 147.
    Jakobiec FA. Granulocytic sarcoma. AJNR Am J Neuroradiol 1991;12(2):263–4.PubMedGoogle Scholar
  148. 148.
    Watkins LM, Remulla HD, Rubin PA. Orbital granulocytic sarcoma in an elderly patient. Am J Ophthalmol 1997;123(6):854–6.PubMedGoogle Scholar
  149. 149.
    Davis JL, Parke DW 2nd, Font RL. Granulocytic sarcoma of the orbit. A clinicopathologic study. Ophthalmology 1985;92(12):1758–62.PubMedGoogle Scholar
  150. 150.
    Zimmerman LE, Font RL. Ophthalmologic manifestations of granulocytic sarcoma (myeloid sarcoma or chloroma). The third Pan American Association of Ophthalmology and American Journal of Ophthalmology Lecture. Am J Ophthalmol 1975;80(6):975–90.PubMedGoogle Scholar
  151. 151.
    Banna M, Aur R, Akkad S. Orbital granulocytic sarcoma. AJNR Am J Neuroradiol 1991;12:255–8.PubMedGoogle Scholar
  152. 152.
    Chung EM, Murphey MD, Specht CS, et al. From the archives of the AFIP. Pediatric orbit tumors and tumorlike lesions: osseous lesions of the orbit. Radiographics 2008;28(4):1193–214.PubMedCrossRefGoogle Scholar
  153. 153.
    Bulas RB, Laine FJ, Das Narla L. Bilateral orbital granulocytic sarcoma (chloroma) preceding the blast phase of acute myelogenous leukemia: CT findings. Pediatr Radiol 1995;25(6):488–9.PubMedCrossRefGoogle Scholar
  154. 154.
    Pomeranz SJ, Hawkins HH, Towbin R, et al. Granulocytic sarcoma (chloroma): CT manifestations. Radiology 1985;155(1):167–70.PubMedGoogle Scholar
  155. 155.
    Pui MH, Fletcher BD, Langston JW. Granulocytic sarcoma in childhood leukemia: imaging features. Radiology 1994;190(3):698–702.PubMedGoogle Scholar
  156. 156.
    Stockl FA, Dolmetsch AM, Saornil MA, et al. Orbital granulocytic sarcoma. Br J Ophthalmol 1997;81(12):1084–8.PubMedCrossRefGoogle Scholar
  157. 157.
    Audouin J, Comperat E, Le Tourneau A, et al. Myeloid sarcoma: clinical and morphologic criteria useful for diagnosis. Int J Surg Pathol 2003;11(4):271–82.PubMedCrossRefGoogle Scholar
  158. 158.
    Tallman MS, Hakimian D, Shaw JM, et al. Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia. J Clin Oncol 1993;11(4):690–7.PubMedGoogle Scholar
  159. 159.
    Ohta K, Kondoh T, Yasuo K, et al. Primary granulocytic sarcoma in the sphenoidal bone and orbit. Childs Nerv Syst 2003;19(9):674–9.PubMedCrossRefGoogle Scholar
  160. 160.
    Lee SG, Park TS, Cheong JW, et al. Preceding orbital granulocytic sarcoma in an adult patient with acute myelogenous leukemia with t(8;21): a case study and review of the literature. Cancer Genet Cytogenet 2008;185(1):51–4.PubMedCrossRefGoogle Scholar
  161. 161.
    Cavdar AO, Babacan E, Gözdaşoğlu S, et al. High risk subgroup of acute myelomonocytic leukemia (AMML) with orbito-ocular granulocytic sarcoma (OOGS) in Turkish children. Retrospective analysis of clinical, hematological, ultrastructural, and therapeutical findings of thirty-three OOGS. Acta Haematol 1989;81(2):80–5.PubMedCrossRefGoogle Scholar
  162. 162.
    Byrd JC, Weiss RB, Arthur DC, et al. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461. J Clin Oncol 1997;15(2):466–75.PubMedGoogle Scholar
  163. 163.
    Schwyzer R, Sherman GG, Cohn RJ, et al. Granulocytic sarcoma in children with acute myeloblastic leukemia and t(8;21). Med Pediatr Oncol 1998;31(3):144–9.PubMedCrossRefGoogle Scholar
  164. 164.
    Bisschop MM, Révész T, Bierings M, et al. Extramedullary infiltrates at diagnosis have no prognostic significance in children with acute myeloid leukaemia. Leukemia 2001;15:46–9.PubMedCrossRefGoogle Scholar
  165. 165.
    Kobayashi R, Tawa A, Hanada R, et al. Japanese childhood AML cooperative study group. Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia. Pediatr Blood Cancer 2007;48(4):393–8.PubMedCrossRefGoogle Scholar
  166. 166.
    Kumar J, Seith A, Bakhshi S, et al. Isolated granulocytic sarcoma of the orbit. Eur J Haematol 2007;78(5):456.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of OphthalmologyKittner Eye Center, University of North Carolina School of MedicineChapel HillUSA
  2. 2.Department of OphthalmologyUniversity of North Carolina School of MedicineChapel HillUSA

Personalised recommendations